<?xml version="1.0" encoding="UTF-8"?>
<p>The study population comprised of 540 patients who had been hospitalized in different wards in two flu seasons (2016-2017 and 2017-2018) between December 2016 and May 2018. Informed consent was obtained from the adults and the legal guardians of the children. The enrolled subjects included patients admitted for moderate to severe onset of respiratory symptoms or for acute onset of fever within the previous week, especially elderly persons and infants, and patients admitted for acute exacerbations of pre-existing chronic medical conditions (e.g. chronic lung disease, asthma, cardiovascular disease, stroke or diabetes). According to guidelines in Laleh hospital, all flu A positive individuals routinely received oseltamivir (Tamiflu) 120 mg for adults and 60 mg for children per day. The study protocol was approved by Laleh hospital ethical committee.</p>
